Key result
Digital health and biotelemetry devices show potential for remote assessment, personalized medicine, and streamlining trials.
Why the study?
Recent technological advances have expanded digital health and biotelemetry, prompting a need to review these concepts and their potential for remote assessment and personalized medicine.
This review highlights the potential of digital health technologies and biotelemetry for remote health assessment, personalized medicine, and streamlining clinical trials.
Hypothesis-generating for remote cardiology monitoring; leaves open the need for RCTs to confirm outcomes and safety.
With the prevalence of digitalization in all aspects of modern society, health assessment is becoming digital too. Taking advantage of the most recent technological advances and approaching medicine from an interdisciplinary perspective has allowed for important progress in healthcare services. Digital health technologies and biotelemetry devices have been more extensively employed for preventing, detecting, diagnosing, monitoring, and predicting the evolution of various diseases, without requiring wires, invasive procedures, or face-to-face interaction with medical personnel. This paper aims to review the concepts correlated to digital health, classify and describe biotelemetry devices, and present the potential of digitalization for remote health assessment, the transition to personalized medicine, and the streamlining of clinical trials.
No takes yet. Share an insight, caveat, or question.
Busnatu et al. (2022) reported a review. Digital health technologies and biotelemetry devices was evaluated. Digital health technologies and biotelemetry devices offer significant potential for remote health assessment, personalized medicine, and the streamlining of clinical trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: